InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,905.47
(
0.18%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

read_this_n0w

Send PM Follow Ignore
Followers 250
Posts 14020
Boards Moderated 3
Alias Born 07/07/2006

read_this_n0w

Re: None

Tuesday, 06/07/2016 6:05:12 AM

Tuesday, June 07, 2016 6:05:12 AM

Post# of 97237
Valeant Pharma sees FY2016 EPS of $6.60-$7.00, versus prior guidance of $8.50-$9.50 and the consensus of $8.47. Valeant Pharma sees FY2016 revenue of $9.9-10.1 billion, versus prior guidance of $11.0-11.2 billion and the consensus of $10.86 billion.

it dropped from 125$ to 28$ in the months prior to releasing these numbers from ealrier highs of 250$

Feedback is allways appreciated, as are other (annotated) picks
Twitter: @RTNRTN To follow on ihub: Ihub mark

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up